190 related articles for article (PubMed ID: 37936974)
1. When Lymphoma Strikes the Pancreas: A Rare Presentation of Systemic Anaplastic Lymphoma Kinase-Negative Anaplastic Large Cell Lymphoma in a Human Immunodeficiency Virus-Positive Patient.
Huang HH; Qing X
J Hematol; 2023 Oct; 12(5):236-242. PubMed ID: 37936974
[TBL] [Abstract][Full Text] [Related]
2. Complete response in a critically ill patient with ALK-negative anaplastic large cell lymphoma treated with single agent brentuximab-vedotin.
Oregel KZ; Everett E; Zhang X; Nagaraj G
Expert Rev Anticancer Ther; 2016; 16(3):279-83. PubMed ID: 26809026
[TBL] [Abstract][Full Text] [Related]
3.
Jiang Y; Wang L; Zhou W; Gu J; Tian Y; Dong Y; Fu L; Wu HB
Cancer Imaging; 2020 Jan; 20(1):4. PubMed ID: 31924270
[TBL] [Abstract][Full Text] [Related]
4. (18)F-FDG PET in Patients with Primary Systemic Anaplastic Large Cell Lymphoma: Differential Features According to Expression of Anaplastic Lymphoma Kinase.
Lee DY; Lee JJ; Kim JY; Park SH; Chae SY; Kim S; Yoon DH; Suh C; Huh J; Ryu JS
Nucl Med Mol Imaging; 2013 Dec; 47(4):249-56. PubMed ID: 24900120
[TBL] [Abstract][Full Text] [Related]
5. Brentuximab vedotin for refractory anaplastic lymphoma kinase-negative anaplastic large cell lymphoma in leukemic phase with
Yamashita Y; Hori Y; Kosako H; Oiwa T; Warigaya K; Mushino T; Murata S; Fujimoto M; Nishikawa A; Murata SI; Sonoki T; Tamura S
Hematol Rep; 2020 May; 12(1):8368. PubMed ID: 32499905
[TBL] [Abstract][Full Text] [Related]
6. Anaplastic Large Cell Lymphoma: Contemporary Concepts and Optimal Management.
Shustov A; Soma L
Cancer Treat Res; 2019; 176():127-144. PubMed ID: 30596216
[TBL] [Abstract][Full Text] [Related]
7. Amplification of genomic DNA demonstrates the presence of the t(2;5) (p23;q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis.
Sarris AH; Luthra R; Papadimitracopoulou V; Waasdorp M; Dimopoulos MA; McBride JA; Cabanillas F; Duvic M; Deisseroth A; Morris SW; Pugh WC
Blood; 1996 Sep; 88(5):1771-9. PubMed ID: 8781434
[TBL] [Abstract][Full Text] [Related]
8. A Rare and Isolated Presentation of Primary Cutaneous Anaplastic Large Cell Lymphoma on the Breast.
Almarzooqi K; Almarzooqi N; Abdelhadi Z
Cureus; 2023 Nov; 15(11):e49387. PubMed ID: 38146564
[TBL] [Abstract][Full Text] [Related]
9. The expressions of MUM-1 and Bcl-6 in ALK-negative systemic anaplastic large cell lymphoma with skin involvement and primary cutaneous anaplastic large cell lymphoma.
Cho YR; Seo JW; Oh SY; Pak MK; Kim KH
Int J Clin Exp Pathol; 2020; 13(7):1682-1687. PubMed ID: 32782689
[TBL] [Abstract][Full Text] [Related]
10. Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas.
Drexler HG; Gignac SM; von Wasielewski R; Werner M; Dirks WG
Leukemia; 2000 Sep; 14(9):1533-59. PubMed ID: 10994999
[TBL] [Abstract][Full Text] [Related]
11. Challenges in utilizing ALK expression to distinguish primary cutaneous from systemic anaplastic large cell lymphoma.
Gleason L; Afifi L; Banner L; Talasila S; Joffe D; Bhatti S; Alpdogan O; Porcu P; Nikbakht N
Mol Clin Oncol; 2024 May; 20(5):35. PubMed ID: 38596625
[TBL] [Abstract][Full Text] [Related]
12. A 15-Year-Old Boy with Primary Maxillary Bone Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma Relapsed with Rib Metastasis after Spontaneous Remission of a Maxillary Bone Lesion: A Case Report and Literature Review.
Aizawa K; Yamazaki F; Shima H; Kurosawa T; Ishikawa T; Nakazawa A; Shimada H
Case Rep Oncol; 2023; 16(1):308-314. PubMed ID: 37187683
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy with brentuximab vedotin and cisplatin/cytarabine in a patient with primarily refractory anaplastic lymphoma kinase positive anaplastic large cell lymphoma.
Heidegger S; Beer AJ; Geissinger E; Rosenwald A; Peschel C; Ringshausen I; Keller U
Onco Targets Ther; 2014; 7():1123-7. PubMed ID: 25018638
[TBL] [Abstract][Full Text] [Related]
14. Anaplastic large cell lymphoma, ALK-negative.
Ferreri AJ; Govi S; Pileri SA; Savage KJ
Crit Rev Oncol Hematol; 2013 Feb; 85(2):206-15. PubMed ID: 22789917
[TBL] [Abstract][Full Text] [Related]
15. Brentuximab vedotin and crizotinib in anaplastic large-cell lymphoma.
Foyil KV; Bartlett NL
Cancer J; 2012; 18(5):450-6. PubMed ID: 23006951
[TBL] [Abstract][Full Text] [Related]
16. Primary bone anaplastic lymphoma kinase positive anaplastic large-cell lymphoma: A case report and review of the literature.
Zheng W; Yin QQ; Hui TC; Wu WH; Wu QQ; Huang HJ; Chen MJ; Yan R; Huang YC; Pan HY
World J Clin Cases; 2021 May; 9(14):3403-3410. PubMed ID: 34002151
[TBL] [Abstract][Full Text] [Related]
17. Anaplastic large cell lymphoma: pathology, genetics, and clinical aspects.
Tsuyama N; Sakamoto K; Sakata S; Dobashi A; Takeuchi K
J Clin Exp Hematop; 2017; 57(3):120-142. PubMed ID: 29279550
[TBL] [Abstract][Full Text] [Related]
18. Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic options.
Querfeld C; Khan I; Mahon B; Nelson BP; Rosen ST; Evens AM
Oncology (Williston Park); 2010 Jun; 24(7):574-87. PubMed ID: 20669794
[TBL] [Abstract][Full Text] [Related]
19. ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination.
ten Berge RL; Oudejans JJ; Ossenkoppele GJ; Pulford K; Willemze R; Falini B; Chott A; Meijer CJ
J Clin Pathol; 2000 Jun; 53(6):445-50. PubMed ID: 10911802
[TBL] [Abstract][Full Text] [Related]
20. CD30-Positive Anaplastic Lymphoma Kinase-Negative Systemic Anaplastic Large-Cell Lymphoma in a 9-Year-Old Boy.
Kim JE; Oh EH; Ro YS; Ko JY
Ann Dermatol; 2016 Jun; 28(3):371-4. PubMed ID: 27274637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]